ATAI Life Sciences NV
NASDAQ:ATAI
During the last 3 months ATAI Life Sciences NV insiders bought 25.3m USD , and sold 246k USD worth of shares. The stock price has increased by 16% over this period (open performance analysis).
The last transaction was made on
Mar 24, 2025
by
Apeiron Investment Group Ltd.
(Shareholder)
, who
bought
2.5m USD
worth of ATAI shares.
During the last 3 months ATAI Life Sciences NV insiders bought 25.3m USD , and sold 246k USD worth of shares. The stock price has increased by 16% over this period (open performance analysis).
The last transaction was made on
Mar 24, 2025
by
Apeiron Investment Group Ltd.
(Shareholder)
, who
bought
2.5m USD
worth of ATAI shares.
ATAI Life Sciences NV
Glance View
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet